Description
Olpid (Zolpidem) 10 mg
Olpid 10 mg is a zolpidem-containing oral hypnotic medicine. Zolpidem is used for short-term treatment of insomnia, particularly when falling asleep is difficult. The product name and strength are treated here as identification details; the verified active ingredient is zolpidem tartrate.
Active Ingredient and Medicine Class
Active ingredient: zolpidem tartrate.
Medicine class: non-benzodiazepine hypnotic, often described as a “Z-drug,” with sedative effects through benzodiazepine receptor activity.
Established Medical Uses
Zolpidem is indicated for the short-term treatment of insomnia characterized by difficulty with sleep initiation. Regulatory labeling also describes its use for reducing sleep latency in controlled studies. It is not presented in the reviewed sources as a general treatment for all sleep complaints.
How It Works
Zolpidem enhances the action of gamma-aminobutyric acid (GABA) at the GABA-A receptor complex, producing a sedative-hypnotic effect. In practical terms, this can help reduce the time needed to fall asleep.
Important Safety Information
Important warnings in official labeling include complex sleep behaviors such as sleep-walking and sleep-driving, which can occur even when the person is not fully awake. Zolpidem should be avoided in severe hepatic impairment because of the risk of hepatic encephalopathy. Caution is also advised in people with compromised respiratory function and in those with depression or suicidal thinking.
Clinically significant interactions include other central nervous system depressants, including alcohol, which may increase additive sedative effects. Opioids may increase the risk of respiratory depression. Labeling also notes interactions with some medicines that affect metabolism.
Possible Side Effects
Commonly reported adverse effects include drowsiness, dizziness, headache and diarrhea. Other recognised effects include drugged feeling, amnesia, daytime sleepiness and next-day impairment. Serious reactions can include complex sleep behaviors, worsening depression, respiratory depression and withdrawal symptoms after abrupt reduction or discontinuation.
Scientific Evidence
Peer-reviewed reviews consistently describe zolpidem as an effective hypnotic for short-term insomnia, with the main clinical benefit being shorter sleep onset time. The literature also highlights the need to monitor for adverse effects such as complex sleep behaviors, dependence potential, residual next-day effects and drug interactions.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or individual assessment by a qualified health professional.
Medical Sources
- DailyMed / FDA: Zolpidem tartrate tablets, oral use, prescribing information. View source
- David J Greenblatt et al. “Zolpidem for insomnia” Expert Opinion on Pharmacotherapy (2012). View PubMed article
